PubMed=2091939; DOI=10.1007/BF00151713
Masanori Kamei, Shuichi Hashizume, Nozomi Sugimoto, Kunihiro Ozutsumi, Morihiro Matsuda;
Establishment of stable mouse/human-human hybrid cell lines producing large amounts of anti-tetanus human monoclonal antibodies with high neutralizing activity.
Eur. J. Epidemiol. 6:386-397(1990)

PubMed=1572415; DOI=10.1007/BF02427384
M. Matsuda, Masanori Kamei, Nozomi Sugimoto, Y. Ma, Shuichi Hashizume;
Characteristics of toxin-neutralization by anti-tetanus human monoclonal antibodies directed against the three functional domains [A], [B] and [C] of the tetanus toxin molecule and a reliable method for evaluating the protective effects of monoclonal antibodies.
Eur. J. Epidemiol. 8:1-8(1992)

DOI=10.1007/978-94-011-2044-9_84
Morihiro Matsuda, Masanori Kamei, Nozomi Sugimoto, Shuichi Hashizume;
Application of anti-tetanus human monoclonal antibodies.
(In book chapter) Animal cell technology. Basic and applied aspects, Vol. 5; Kaminogawa, Shuichi & Ametani, Akio & Hachimura, Satoshi (eds.); pp.617-623; Springer; Dordrecht; Netherlands (1993)